Home > Journals > Minerva Urologica e Nefrologica > Past Issues > Minerva Urologica e Nefrologica 2010 June;62(2) > Minerva Urologica e Nefrologica 2010 June;62(2):203-11

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA UROLOGICA E NEFROLOGICA

A Journal on Nephrology and Urology


Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,984


eTOC

 

  PROSTATE CANCER FORUM


Minerva Urologica e Nefrologica 2010 June;62(2):203-11

Copyright © 2010 EDIZIONI MINERVA MEDICA

language: English

The role of brachytherapy in the 21st century for prostate cancer

Mabjeesh N. J., Matzkin H.

Department of Urology, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University,


PDF  


Men presenting with clinically confined prostate cancer have a variety of established treatment options, among them brachytherapy is gaining increased acceptance, even in the absence of randomized comparative data between brachytherapy, surgery and external radiotherapy. This review summarizes the results of low dose rate transrectal-guided transperineal permanent seed implantation brachytherapy. We present the evolution of the different treatment planning techniques and a comprehensive review of published mature data on 10-year or longer of biochemical and survival outcome for brachytherapy alone, and brachytherapy combined with supplemental external beam radiation therapy with emphasis on its impact on quality of life.

top of page

Publication History

Cite this article as

Corresponding author e-mail

nicolam@tasmc.health.gov.il